Short answer
Psilocybin is a naturally occurring psychedelic compound made by more than 200 species of mushrooms, the ones people call magic mushrooms or shrooms. Your body converts it into psilocin, which switches on serotonin 5-HT2A receptors in your brain and produces a four to six hour experience of altered perception, emotion, and thinking. It's federally illegal in the U.S. but legal in licensed programs in Oregon, Colorado, and New Mexico, and it's on track to become an FDA-approved depression treatment.
Key takeaways
- Psilocybin is made by mushrooms, mostly in the genus Psilocybe, which has existed for roughly 65 million years.
- It's a prodrug. Your body turns it into psilocin, the molecule that actually does the work.
- Physically, it's one of the least toxic drugs we know of. The real risks are psychological.
- Synthetic psilocybin has passed two Phase 3 trials for treatment-resistant depression.
Where psilocybin comes from
Psilocybin is made by mushrooms. Most of them belong to the genus Psilocybe, which includes about 165 known species, and a 2024 genetic study traced the genus back roughly 65 million years, to around the time an asteroid wiped out the dinosaurs.1 Scattered species in other genera, like Panaeolus, Gymnopilus, and Inocybe, make it too, which is how you get to the commonly cited figure of 200-plus psilocybin species worldwide.
People in Mesoamerica used these mushrooms ceremonially for centuries before Western science noticed. Swiss chemist Albert Hofmann, the same person who discovered LSD, isolated and named psilocybin in 1958 from mushrooms collected in Mexico.2 For a while, the drug company Sandoz even sold it to researchers. Then came prohibition, and the research went quiet for about 30 years. More on that in the history of magic mushrooms.
How psilocybin works
Psilocybin itself is basically a delivery vehicle. Once you swallow it, enzymes strip off its phosphate group and turn it into psilocin, which crosses into the brain.3 Psilocin looks a lot like serotonin, your brain's own mood and perception chemical, and it locks onto the serotonin 2A (5-HT2A) receptor. The more of those receptors it occupies, the stronger the experience.4
The result is a few hours where your brain runs differently. Networks that normally keep to themselves start talking, the part of your brain responsible for your running inner monologue goes quiet, and your visual system gets creative. We break all of that down in what shrooms do to your brain.
What it feels like
Effects usually start 20 to 40 minutes after you take it, peak around the 90-minute mark, and taper off over four to six hours.3 People commonly report:
- Brighter colors, patterns, and surfaces that seem to breathe
- Waves of emotion, from laughter to tears, sometimes within minutes
- A sense of connection to other people, nature, or something bigger
- Distorted sense of time
- Nausea early on, plus dilated pupils and a faster heart rate
It can also be scary. Anxiety, paranoia, and confusion are real possibilities, especially at higher doses or in the wrong environment. See what shrooms feel like and bad trips for the full picture.
Is psilocybin safe?
Physically, psilocybin is remarkably low-risk. When a panel of drug experts ranked 20 substances by harm to users and others in The Lancet, magic mushrooms came in dead last, the least harmful on the list.5 Alcohol came in first. In a survey of more than 9,000 people who used magic mushrooms, just 0.2% said they had ever needed emergency medical treatment, and nearly all of them were back to normal within a day.6
That doesn't make it harmless. The dangers are mostly psychological and situational: panic, risky behavior while impaired, and in people with a personal or family history of psychosis or bipolar disorder, the possibility of triggering a serious episode. Read who should not take psilocybin before you go anywhere near it.
Why medicine wants it back
Here's the part that matters most. In 2026, Compass Pathways reported results from its second Phase 3 trial of synthetic psilocybin for treatment-resistant depression, in people who had already tried multiple treatments that didn't work. In that study, 39% of patients who got two doses responded, and most kept that benefit for at least six months.7 A New Drug Application is in front of the FDA now.
Researchers are also studying psilocybin for alcohol use disorder, smoking, PTSD, anxiety in people with cancer, and more. Our guide to what psilocybin can treat sorts those uses by how strong the evidence actually is.
Is psilocybin legal?
Federally, no. Psilocybin is still Schedule I, and the DEA's 2026 decision to reschedule marijuana didn't touch it.8 But Oregon and Colorado run legal, state-licensed psilocybin programs for adults 21 and over, New Mexico is building a medical program, and a handful of cities have made it their lowest enforcement priority. The full breakdown is in psilocybin laws by state, and you can search for licensed providers in our psilocybin therapist finder.
Common questions
Is psilocybin the same thing as magic mushrooms?
Not quite. Magic mushrooms are the whole fungus, which contains psilocybin plus smaller amounts of related compounds like psilocin, baeocystin, and norbaeocystin. Clinical trials use pure synthetic psilocybin so every dose is identical.
Is psilocybin a drug or a supplement?
Legally, it's a Schedule I controlled substance in the U.S., not a supplement. Products sold online as "mushroom gummies" are unregulated and often don't contain what the label says.
Is psilocybin natural?
Yes. Mushrooms make it on their own, and scientists have identified the genes they use to do it. It can also be made synthetically, which is what drug companies use.
Sources
- Bradshaw AJ, et al. Phylogenomics of the psychoactive mushroom genus Psilocybe and evolution of the psilocybin biosynthetic gene cluster. PNAS. 2024. doi.org/10.1073/pnas.2311245121
- Hofmann A, et al. Psilocybin, a psychotropic substance from the Mexican mushroom Psilocybe mexicana. Experientia. 1958. doi.org/10.1007/BF02159243
- Passie T, et al. The pharmacology of psilocybin. Addiction Biology. 2002. doi.org/10.1080/1355621021000005937
- Madsen MK, et al. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels. Neuropsychopharmacology. 2019. doi.org/10.1038/s41386-019-0324-9
- Nutt DJ, King LA, Phillips LD. Drug harms in the UK: a multicriteria decision analysis. The Lancet. 2010. doi.org/10.1016/S0140-6736(10)61462-6
- Kopra EI, et al. Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms. Journal of Psychopharmacology. 2022. PMC9353971
- Compass Pathways. Six month data from second Phase 3 trial confirming rapid and durable profile. July 7, 2026. businesswire.com
- National Law Review. What the marijuana rescheduling order means for psychedelics. May 13, 2026. natlawreview.com
This article is for education only and is not medical or legal advice. Psilocybin is a Schedule I substance under U.S. federal law. Talk with a licensed clinician before making decisions about your health. In a crisis, call or text 988.